NSEMonitoring Agency Report1d ago · 4 Nov 2026, 11:43 am

Monitoring Agency Report

Awfis Space Solutions Limited · AWFIS

✦ AI SummaryResults

Awfis Space Solutions Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, as per SEBI Regulations and Monitoring Agency Agreement dated May 10, 2024, to the National Stock Exchange of India Limited and BSE Limited.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Monitoring Agency Report for the quarter ended September 30, 2026 is attached herewith.

Attachments (1)

📄

AWFIS2014_04112026114249_MA_Intimation_Signed.pdf

pdf

Download →
View document text
awfis Date: November 04, 2026 To, To, National Stock Exchange of India Limited (“NSE”) BSE Limited (“BSE”) Listing Department Listing Department Exchange Plaza, C-1 Block G, Corporate Relationship Department Bandra Kurla Complex Bandra [E], Phiroze Jeejeebhoy Towers, Mumbai – 400051 Dalal Street, Fort, Mumbai – 400001 NSE Scrip Symbol: AWFIS BSE Scrip Code: 544181 ISIN: INE108V01019 ISIN: INE108V01019 Subject: Monitoring Agency Report for the quarter ended September 30, 2026 Dear Sir/Madam, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended from time to time, please find enclosed herewith the Monitoring Agency Report for the quarter ended September 30, 2026, issued by CARE Ratings Limited, duly reviewed and taken on record by the Audit Committee & the Board of Directors of the Company. The above information will also be available on the website of the Company at https://www.awfis.com/investor-relations/initial-public-offer/financials. We request you to kindly take this on your record. Thanking You. For Awfis Space Solutions Limited Shweta Gupta Company Secretary and Compliance Officer M. No. F8573 Address: C-28-29, Kissan Bhawan, Qutab Institutional Area, New Delhi – 110016 Encl: as above Corporate and Regd. Office Awfis Space Solutions Limited C-28-29, Kissan Bhawan, Qutab Institutional Area, New Delhi – 110016 www.awfis.com | Email: info@awfis.com | Phone: 011- 41103497 CIN: L74999DL2014PLC274236 CareEdge RATINGS No. CARE/NRO/GEN/2026-27/1156 The Board of Directors Awfis Space Solutions Limited C-28-29, Kissan Bhawan, Qutab Institutional Area, South Delhi New Delhi, Delhi, India, 110016 November 04, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the IPO of Awfis Space Solutions Limited (“the Company”) We write in our capacity of Monitoring Agency for the IPO for the amount aggregating to Rs. 128.0 crore of the Company and refer to our duties cast under Regulation 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated May 10, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Akhil Kumar Associate Director akhil.kumar@careedge.in CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 CareEdge RATINGS Report of the Monitoring Agency Name of the issuer: Awfis Space Solutions Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name of the Authorized Signatory: Akhil Kumar Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 CareEdge RATINGS 1) Issuer Details: Name of the issuer : Awfis Space Solutions Limited Name of the promoter(s) : Amit Ramani & Moneesha Ramani Industry/sector to which it belongs : Flexible workspace Solutions service provider 2) Issue Details Issue Period : 22/05/2024 to 27/05/2024 Type of issue (public/rights) : Public Type of specified securities : Equity IPO Grading, if any : - Issue size (in Rs. crore) : Rs. 128.00 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors The issue proceeds have been Whether all utilization is as per the disclosures in the Offer CA Certificate*, Management Certificate, utilized in accordance with the Yes No comments Document? Offer document, Bank Statements objects given as per offer documents during Q2FY27 Whether shareholder approval has been obtained in case of material deviations# from expenditures disclosed in the Offer NA Management Certificate Not Applicable No comments Document? Whether the means of finance for the disclosed objects of the issue Management Certificate No Not applicable No comments have changed? Is there any major deviation observed over the earlier monitoring Management Certificate No Not applicable No comments agency reports? Whether all Government/statutory approvals related to the No approval Management Certificate Not applicable No comments CARE Ratings Limited Plot no. C-001 A/2 Sector 16B, Berger Tower, Noida, Gautam 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Budh Nagar (UP) - 201301 Phone: +91-120-4452 000 Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in CIN-L67190MH1993PLC071691 CareEdge RATINGS Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors object(s) have been obtained? Required Whether all arrangements pertaining to technical Management Certificate NA Not applicable No comments assistance/collaboratio [Showing first 8,000 characters — download PDF for full document]